Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ·Healthcare·Biotechnology
$28.97
-1.81%
Mkt Cap $3.62B
Analyst Ratings
Buy
10
Hold
0
Sell
0
Price Target (28 analysts)
$52.20
Range $42.00 – $57.00
Implied Upside
+80.2%
Consensus $52.20 vs current $28.97
NASDAQ·Healthcare·Biotechnology
$28.97
-1.81%
Mkt Cap $3.62B
Buy
10
Hold
0
Sell
0
Price Target (28 analysts)
$52.20
Range $42.00 – $57.00
+80.2%
Consensus $52.20 vs current $28.97